<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:54:21Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10889" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10889</identifier><datestamp>2026-10-18T20:39:17Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The effects of dexmedetomidine and ketamine infusions on the inflammatory response in liver resection: A randomized double-blind placebo study</dc:title><dc:creator>Ates, Irem</dc:creator><dc:creator>Laloglu, Esra</dc:creator><dc:creator>Kara, Salih</dc:creator><dc:creator>Yaman, Tuba</dc:creator><dc:creator>Isik, Bahar</dc:creator><dc:subject>dexmedetomidine</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>infusion</dc:subject><dc:subject>ketamine</dc:subject><dc:subject>liver resection</dc:subject><dc:subject>pain</dc:subject><dc:subject>Adolescent</dc:subject><dc:subject>Adult</dc:subject><dc:subject>Aged</dc:subject><dc:subject>Analgesics</dc:subject><dc:subject>C-Reactive Protein</dc:subject><dc:subject>Double-Blind Method</dc:subject><dc:subject>Female</dc:subject><dc:subject>Hepatectomy</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Infusions, Intravenous</dc:subject><dc:subject>Male</dc:subject><dc:subject>Middle Aged</dc:subject><dc:subject>Pain Measurement</dc:subject><dc:subject>Pain, Postoperative</dc:subject><dc:subject>Serum Amyloid A Protein</dc:subject><dc:subject>Serum Amyloid P-Component</dc:subject><dc:subject>Young Adult</dc:subject><dc:subject>fentanyl</dc:subject><dc:subject>hepcidin</dc:subject><dc:subject>ketax</dc:subject><dc:subject>paracetamol</dc:subject><dc:subject>pentraxin 3</dc:subject><dc:subject>propofol</dc:subject><dc:subject>rocuronium</dc:subject><dc:description>Background: This study compared the effects of ketamine and dexmedetomidine (Dex) on inflammation and pain in liver resection surgery. Methods: Forty-five American Society of Anesthesiologists class III patients aged 18 to 65 scheduled for liver resection surgery were randomized into 3 equal groups. The ketamine group received an intravenous ketamine bolus (0.5 mg/kg) during anesthesia induction and continuous low-dose infusion at 0.25 mg/kg/hour. In the Dex group, intravenous infusion was initiated at a 1 µg/kg bolus for the first 10 minutes, and at 0.5 µg/kg/hour after intubation. The control group patients were infused crystalloid solution at 8 mL/kg/hour from induction. Venous blood was collected at postoperative hours 1 and 12 for pentraxin 3, serum amyloid A, hepcidin, and inflammatory marker analysis. Visual analogue scale (VAS) values were recorded. Results: Pentraxin 3, serum amyloid A, and hepcidin continued to rise at 12 hours in the control group, but began declining in the Dex and ketamine infusion groups (P&lt;.05). VAS levels and fentanyl consumption decreased in the ketamine and Dex groups compared to the control group (P&lt;.05). The decreases in inflammatory parameters, VAS scores, and fentanyl consumption were similar between the ketamine and Dex groups (P&gt;.05). A positive correlation was observed between inflammation levels and pain severity (P&lt;.001). There was no difference in liver function tests between any of the groups (P&lt;.05). Conclusion: Ketamine and Dex infusions were both effective in reducing inflammation and pain following liver resection, with no obvious superiority of one over the other.  © 2025 the Author(s).</dc:description><dc:publisher>Lippincott Williams and Wilkins</dc:publisher><dc:date>2025</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10889</dc:identifier><dc:identifier>https://doi.org/10.1097/md.0000000000042999</dc:identifier><dc:identifier>0025-7974</dc:identifier><dc:language>en</dc:language><dc:relation>Medicine (United States)</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10889</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>